One Los Angeles school is working technology into the learning process while avoiding traditional screen-time pitfalls.
The Liberian physician, who operates a clinic in the capital, perseveres in the wake of a colleague's death, possibly from Ebola. She and her staff continue to treat patients.
New drugs and vaccines can take years to develop. But health officials and researchers are accelerating tests of experimental drugs to fight the outbreak in West Africa.
Most U.S. poultry is bathed in a little chlorine on the way to your plate. But that treatment is banned in Europe. Now "chlorinated chickens" are a sticking point in a trans-Atlantic trade deal.
In writing her new book On Immunity, Eula Biss found that questions about vaccination touch on attitudes about environmentalism, citizenship and trust in the government.
American doctors received at least $1.4 billion in payments from drug companies last year. What did the companies get for their money?
Voters in New Hampshire's 1st District have swung back and forth in recent congressional elections. This year, Democratic Rep. Carol Shea-Porter meets former GOP Rep. Frank Guinta for the third time.
The largest archaeological find of its kind in Greece has set off speculation and thrilled Greeks, reminding them they are rich in history.
Rochester, N.Y., was once the imaging capital of the world, home to Kodak, Xerox and Bausch + Lomb. Now, with a drastically cut manufacturing sector, the city is trying to build something new.
One major study found sexual assaults are lower on campuses of historically black colleges and universities. But some question those numbers and whether HBCUs have the resolve to address the issue.